Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Tomoharu Yoshizumi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4497-1816; OpenAlex author ID A5037162068. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 3 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospecti… Co-author DOI 10.1002/ags3.70090↗
  2. Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoper… Last author DOI 10.1007/s10147-023-02399-7↗
  3. A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0288033↗
  4. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study. Co-author DOI 10.1016/j.pan.2021.08.003↗
  5. Impact of Capicua on Pancreatic Cancer Progression. Co-author DOI 10.1245/s10434-020-09339-z↗
  6. ASO Author Reflections: A New Prognostic Factor for Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-09386-6↗
  7. Efficacy of Neoadjuvant Chemotherapy in Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP-CAR) for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1007/s11605-019-04324-8↗
  8. Colonic varices: a rare complication of pancreatic cancer. Co-author DOI 10.1007/s12328-020-01225-1↗
  9. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.07.011↗
  10. IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer. First author DOI 10.1016/j.jss.2019.02.038↗
  11. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer. First author DOI 10.1002/cam4.1087↗
  12. Surgical Results of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Multi-institutional Retrospective Study of 174 patients. First author PMID 27127150↗
  13. Recurrence 11 years after complete response to gemcitabine, 5-Fluorouracil, and Cisplatin chemotherapy followed by radiotherapy in a patient with advanced panc… Co-author PMID 25964569↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinji Itoh · 10 shared papers, 2015–2023 · strength 1.01
  2. Masaki Mori · 5 shared papers, 2020–2021 · strength 0.61
  3. Keishi Sugimachi · 5 shared papers, 2016–2023 · strength 0.55
  4. Shohei Yoshiya · 4 shared papers, 2020–2021 · strength 0.50
  5. Toru Ikegami · 5 shared papers, 2016–2020 · strength 0.40
  6. Hiromitsu Hayashi · 2 shared papers, 2023–2026 · strength 0.37
  7. Yoshinao Oda · 4 shared papers, 2017–2021 · strength 0.37
  8. Mototsugu Shimokawa · 2 shared papers, 2023 · strength 0.31
  9. Yoshihiko Maehara · 4 shared papers, 2015–2019 · strength 0.25
  10. Tohru Utsunomiya · 2 shared papers, 2021–2023 · strength 0.25
  11. Toru Hisaka · 1 shared paper, 2026 · strength 0.23
  12. Yasuhisa Mori · 1 shared paper, 2026 · strength 0.23
  13. Teijiro Hirashita · 1 shared paper, 2026 · strength 0.23
  14. Masafumi Nakamura · 1 shared paper, 2026 · strength 0.23
  15. Hiroaki Nagano · 1 shared paper, 2026 · strength 0.23
  16. Susumu Eguchi · 1 shared paper, 2026 · strength 0.23
  17. Hirokazu Noshirο · 1 shared paper, 2026 · strength 0.23
  18. Hiroto Matsui Matsui · 1 shared paper, 2026 · strength 0.23
  19. Shingo Kozono · 1 shared paper, 2026 · strength 0.23
  20. Hirohisa Okabe · 1 shared paper, 2026 · strength 0.23
  21. Naoki Ikenaga · 1 shared paper, 2026 · strength 0.23
  22. Kyohei Yugawa · 2 shared papers, 2020–2021 · strength 0.21
  23. Tomohiro Iguchi · 2 shared papers, 2020–2021 · strength 0.20
  24. Hideo Baba · 2 shared papers, 2015–2023 · strength 0.19
  25. Shoichi Inokuchi · 2 shared papers, 2020 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.